IN2015DN03796A - - Google Patents
Info
- Publication number
- IN2015DN03796A IN2015DN03796A IN3796DEN2015A IN2015DN03796A IN 2015DN03796 A IN2015DN03796 A IN 2015DN03796A IN 3796DEN2015 A IN3796DEN2015 A IN 3796DEN2015A IN 2015DN03796 A IN2015DN03796 A IN 2015DN03796A
- Authority
- IN
- India
- Prior art keywords
- gene signatures
- autoimmune disorders
- metabolic
- inflammation
- disorders
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
- C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/16—Primer sets for multiplex assays
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12306286 | 2012-10-17 | ||
| PCT/EP2013/071793 WO2014060555A1 (fr) | 2012-10-17 | 2013-10-17 | Signatures géniques de troubles inflammatoires qui sont associés au foie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN03796A true IN2015DN03796A (fr) | 2015-10-02 |
Family
ID=47148686
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN3796DEN2015 IN2015DN03796A (fr) | 2012-10-17 | 2013-10-17 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US10036074B2 (fr) |
| EP (1) | EP2909334B1 (fr) |
| JP (2) | JP6752016B2 (fr) |
| CN (1) | CN104769132B (fr) |
| AU (2) | AU2013333882B2 (fr) |
| BR (1) | BR112015008621A2 (fr) |
| CA (1) | CA2886748A1 (fr) |
| DK (1) | DK2909334T3 (fr) |
| ES (1) | ES2821383T3 (fr) |
| IL (1) | IL238025B (fr) |
| IN (1) | IN2015DN03796A (fr) |
| MX (1) | MX2015004844A (fr) |
| NZ (1) | NZ707035A (fr) |
| WO (1) | WO2014060555A1 (fr) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013139861A1 (fr) | 2012-03-20 | 2013-09-26 | Luc Montagnier | Procédés et compositions pharmaceutiques pour le traitement de troubles du syndrome de l'autisme |
| CN115919906A (zh) | 2016-03-04 | 2023-04-07 | 加利福尼亚大学董事会 | 微生物聚生体及其用途 |
| AU2017252299A1 (en) * | 2016-04-20 | 2018-12-06 | Human Longevity, Inc. | Use of a microbiome profile to detect liver disease |
| MX2018013727A (es) * | 2016-05-11 | 2019-08-29 | Univ Southern California | Dieta imitadora del ayuno (fmd) como un tratamiento inmunoregulador para enfermedades gastrointestinales autoinmunes/inflamatorias. |
| US11284640B2 (en) | 2017-02-14 | 2022-03-29 | University Of Southern California | Fasting mimicking diet |
| WO2018187272A1 (fr) | 2017-04-03 | 2018-10-11 | Gusto Global, Llc | Conception rationnelle d'agents biothérapeutiques d'origine microbienne |
| CN107271674B (zh) * | 2017-06-13 | 2019-05-07 | 首都医科大学附属北京地坛医院 | 一种用于脂肪性肝炎检测的靶标志物gp73及检测应用方法 |
| EP3773645A4 (fr) | 2018-04-10 | 2021-11-24 | Siolta Therapeutics, Inc. | Consortia microbiens |
| CN108504739A (zh) * | 2018-05-15 | 2018-09-07 | 浙江大学 | 一种用于肝癌早期诊断的生物标志物及其应用 |
| EP3899015A1 (fr) * | 2018-12-19 | 2021-10-27 | Astrazeneca AB | Biomarqueur de l'expression de pnpla3 |
| CA3128973A1 (fr) | 2019-03-04 | 2020-09-10 | Bhaskar Bhattacharyya | Compression et communication de donnees a l'aide d'un apprentissage automatique |
| KR20220108765A (ko) | 2019-10-07 | 2022-08-03 | 시올타 테라퓨틱스, 인크. | 치료용 약학 조성물 |
| CN111884792B (zh) * | 2020-06-30 | 2021-07-09 | 深圳市永达电子信息股份有限公司 | 基于忆阻器混沌序列的本征态网络电路信号制备系统和方法 |
| US11688507B2 (en) | 2020-12-29 | 2023-06-27 | Kpn Innovations, Llc. | Systems and methods for generating a metabolic dysfunction nourishment program |
| US20230193392A1 (en) * | 2021-12-20 | 2023-06-22 | Regeneron Pharmaceuticals, Inc. | Methods Of Identifying And Evaluating Liver Inflammation And Liver Fibrosis In A Subject By Determining A Stratified Score Based On Gene Expression |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6582908B2 (en) * | 1990-12-06 | 2003-06-24 | Affymetrix, Inc. | Oligonucleotides |
| US6610836B1 (en) * | 1999-01-29 | 2003-08-26 | Genome Therapeutics Corporation | Nucleic acid amino acid sequences relating to Klebsiella pneumoniae for diagnostics and therapeutics |
| EP1268774A2 (fr) * | 2000-03-21 | 2003-01-02 | Elitra Pharmaceuticals, Inc. | Identification de genes esentiels dans des procaryotes |
| EP1227152A1 (fr) * | 2001-01-30 | 2002-07-31 | Société des Produits Nestlé S.A. | Souche bactérienne et genome de bifidobacterium |
| CA2476755C (fr) * | 2001-12-17 | 2014-08-26 | Corixa Corporation | Compositions et procedes applicables a la therapie et au diagnostic pour la maladie intestinale inflammatoire |
| US8119365B2 (en) * | 2002-01-23 | 2012-02-21 | Wisconsin Alumni Research Foundation | Insertion sequence-free bacteria |
| JPWO2004092365A1 (ja) * | 2003-04-13 | 2006-07-06 | 株式会社産学連携機構九州 | 肝障害関連遺伝子群の抽出選択法およびそれを用いた肝障害もしくは肝機能評価・診断方法 |
| US7860656B2 (en) * | 2005-02-03 | 2010-12-28 | Assistance Publique-Hopitaux De Paris (Ap-Hp) | Diagnosis method of hepatic steatosis using biochemical markers |
| ES2595363T3 (es) * | 2005-02-18 | 2016-12-29 | J. Craig Venter Institute, Inc. | Sepsis asociada a las proteínas y los ácidos nucleicos de meningitis / Escherichia coli |
| FR2893136A1 (fr) * | 2005-11-10 | 2007-05-11 | Sanofi Aventis Sa | Procedes de diagnostic de maladies hepatiques et de criblage de molecules pour le traitement de ces maladies |
| US20110165568A1 (en) * | 2009-12-31 | 2011-07-07 | Life Technologies Corporation | Sequences of e.coli 055:h7 genome |
| CN102939391A (zh) * | 2010-03-01 | 2013-02-20 | 国家农艺研究院 | 炎症性肠病的诊断方法 |
| JP5757032B2 (ja) * | 2010-04-05 | 2015-07-29 | 学校法人東京医科大学 | ｍｉＲＮＡを利用した慢性肝疾患の線維化の検査方法 |
| JP2012125215A (ja) * | 2010-12-17 | 2012-07-05 | Osaka City Univ | 肝線維症の存在及び／又は肝線維症の重症度の判定方法、判定マーカー、判定用キット、肝線維症の治療の効果予測方法、効果予測マーカー、並びに効果予測用キット |
| WO2012105590A1 (fr) * | 2011-02-01 | 2012-08-09 | アステラス製薬株式会社 | Marqueur de détermination pour une stéatose hépatique non alcoolique et méthode de diagnostic d'une stéatose hépatique non alcoolique à l'aide du marqueur en tant que mesure |
| WO2012159023A2 (fr) * | 2011-05-19 | 2012-11-22 | Virginia Commonwealth University | Microflore de l'intestin servant de biomarqueur dans le pronostic de la cirrhose et du dysfonctionnement cérébral |
| WO2013036290A1 (fr) | 2011-09-09 | 2013-03-14 | Yale University | Compositions et procédés d'évaluation et de traitement de maladies et de troubles inflammatoires |
| US20140377278A1 (en) * | 2012-01-10 | 2014-12-25 | Yale University | Compositions and Methods for Assessing and Treating Inflammatory Diseases and Disorders |
| CA2888427A1 (fr) | 2012-10-17 | 2014-04-24 | Institut National De La Recherche Agronomique | Pronostic de l'impact d'un regime alimentaire sur des comorbidites liees a l'obesite |
| EP2909332A1 (fr) | 2012-10-17 | 2015-08-26 | Institute National de la Recherche Agronomique | Détermination d'une tendance à la prise de poids |
| DK2909336T3 (en) | 2012-10-17 | 2018-08-20 | Agronomique Inst Nat Rech | DETERMINATION OF REDUCED GAS BACTERIA DIVERSITY |
| US9459650B2 (en) | 2014-03-17 | 2016-10-04 | Qualcomm Incorporated | Clock pulse generator for multi-phase signaling |
-
2013
- 2013-10-17 IN IN3796DEN2015 patent/IN2015DN03796A/en unknown
- 2013-10-17 US US14/435,750 patent/US10036074B2/en active Active
- 2013-10-17 ES ES13779214T patent/ES2821383T3/es active Active
- 2013-10-17 DK DK13779214.9T patent/DK2909334T3/da active
- 2013-10-17 CN CN201380054047.XA patent/CN104769132B/zh not_active Expired - Fee Related
- 2013-10-17 AU AU2013333882A patent/AU2013333882B2/en not_active Ceased
- 2013-10-17 NZ NZ707035A patent/NZ707035A/en not_active IP Right Cessation
- 2013-10-17 JP JP2015537267A patent/JP6752016B2/ja not_active Expired - Fee Related
- 2013-10-17 MX MX2015004844A patent/MX2015004844A/es active IP Right Grant
- 2013-10-17 WO PCT/EP2013/071793 patent/WO2014060555A1/fr active Application Filing
- 2013-10-17 CA CA2886748A patent/CA2886748A1/fr not_active Abandoned
- 2013-10-17 BR BR112015008621-7A patent/BR112015008621A2/pt not_active Application Discontinuation
- 2013-10-17 EP EP13779214.9A patent/EP2909334B1/fr active Active
-
2015
- 2015-03-30 IL IL238025A patent/IL238025B/en active IP Right Grant
-
2018
- 2018-05-07 US US15/972,620 patent/US10626471B2/en active Active
-
2019
- 2019-03-05 JP JP2019039947A patent/JP2019092522A/ja active Pending
- 2019-08-02 AU AU2019210666A patent/AU2019210666A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019092522A (ja) | 2019-06-20 |
| EP2909334A1 (fr) | 2015-08-26 |
| US10036074B2 (en) | 2018-07-31 |
| EP2909334B1 (fr) | 2020-06-24 |
| DK2909334T3 (da) | 2020-09-28 |
| AU2013333882A1 (en) | 2015-05-07 |
| IL238025B (en) | 2020-05-31 |
| US20160068890A1 (en) | 2016-03-10 |
| WO2014060555A1 (fr) | 2014-04-24 |
| ES2821383T3 (es) | 2021-04-26 |
| IL238025A0 (en) | 2015-05-31 |
| JP6752016B2 (ja) | 2020-09-09 |
| US20180251819A1 (en) | 2018-09-06 |
| NZ707035A (en) | 2018-11-30 |
| JP2015535177A (ja) | 2015-12-10 |
| MX2015004844A (es) | 2015-11-16 |
| AU2013333882B2 (en) | 2019-05-16 |
| CN104769132B (zh) | 2018-05-08 |
| CN104769132A (zh) | 2015-07-08 |
| BR112015008621A2 (pt) | 2018-08-28 |
| AU2019210666A1 (en) | 2019-08-22 |
| CA2886748A1 (fr) | 2014-04-24 |
| US10626471B2 (en) | 2020-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN03796A (fr) | ||
| MX2016002879A (es) | Sistemas, dispositivos y metodos para la terapia anti-tl1a. | |
| MX2016014624A (es) | Metodos para el tratamiento de enfermedad inflamatoria del intestino. | |
| WO2012047631A3 (fr) | Compositions et procédés utiles dans le traitement et le diagnostic d'une maladie intestinale inflammatoire | |
| NZ602704A (en) | Method of diagnostic of inflammatory bowel diseases | |
| MX2015015784A (es) | Metodos para diagnosticar y tratar enfermedad inflamatoria de intestino. | |
| MX2017015210A (es) | Composiciones y metodos para el cribado de tumores solidos. | |
| UA115540C2 (uk) | Антитіло до il-36r | |
| IN2014MN01642A (fr) | ||
| PH12016502167A1 (en) | Hdl theraphy markers | |
| MX2022012384A (es) | Composiciones y metodos para cribar mutaciones en el cancer de tiroides. | |
| MX2016002423A (es) | Composiciones y metodos de diagnostico para el tratamiento de glioblastoma. | |
| MX2022010809A (es) | Antagonistas de integrina-beta7 para usarse en el tratamiento y diagnostico de trastornos inflamatorios gastrointestinales. | |
| MX2012008730A (es) | Metodos y composiciones para prediccion de riesgo, diagnosis, prognosis y tratamiento de desordenes pulmonares. | |
| NZ738100A (en) | Igfbp3 and uses thereof | |
| MA39710A (fr) | Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin | |
| BR112017014107A2 (pt) | composição nutricional útil no tratamento de pacientes com ibd | |
| WO2015132670A3 (fr) | Procédés et compositions de détection de cibles pour les maladies auto-immunes | |
| MX2022008842A (es) | Proteinas para el tratamiento de trastornos de la funcion de la barrera epitelial. | |
| ZA201408059B (en) | Compositions and methods for the treatment of inflammatory bowel disease | |
| EP3052661A4 (fr) | Méthodes pour évaluer l'état du foie après une transplantation et pour déterminer et administrer des schémas de traitement spécifiques | |
| MA40592A (fr) | Compositions et méthodes pour le traitement d'une maladie inflammatoire de l'intestin à l'aide d'une polythérapie à base d'inhibiteurs à petites molécules de récepteur 9 de chimiokine c-c (ccr9) et d'anticorps bloquants anti-intégrine alpha4beta7 | |
| MX2017006959A (es) | Metodos para establecer un regimen de dosificacion de vedolizumab para tratar pacientes con enfermedad del intestino irritable. | |
| IN2014DN06662A (fr) | ||
| WO2013106766A3 (fr) | Indications thérapeutiques du miarn-1291 |